Company / Operating Cash Flow per Share
Caris Life Sciences, Inc. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.28
FY2025
5-year range
-$7.90 / $2.28
FY2023-FY2025
Trend
+133.0%
vs FY2024
Sector context
#84 of 162
Health Care
What the data says
At $2.28, Caris Life Sciences, Inc.'s operating cash flow per share ranks #84 of 162 in the Health Care sector. Improved from $-7.90 to $2.28 over the past 2 years.
Based on SEC 10-K filings.
2.28 in FY2025.
Improved from $-7.90 to $2.28 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 162 in Health CareTop 52% of 162This company $2.28 Sector average $6.63
▼
-65.7% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 133.0% year-over-year.
- Ranks #84 out of 162 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.28 | +133.0% |
| FY2024 | -$6.91 | +12.6% |
| FY2023 | -$7.90 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026